Research Conducted at the Vaccine Research Center (VRC)


Immunology Laboratory

The mission of the Immunology Laboratory (IML) is to investigate novel aspects of the cellular immune response to pathogens in support of the rational development of a vaccine against HIV and other lethal human viral pathogens.

Viral Pathogenesis Laboratory

The goal of the Viral Pathogenesis Laboratory (VPL) is to better understand basic aspects of viral pathogenesis and apply that knowledge toward development of safer and more effective vaccines.

Virology Laboratory

The mission of the Vaccine Research Center (VRC) is to translate basic scientific knowledge into vaccine products intended for clinical use. In order to carry out the development and analysis of new vaccine candidates, the VRC has established several laboratories, including the Virology Laboratory (VL).


Clinical Trials Program

The primary mission of the VRC Clinical Trials Program (CTP) is to carry out clinical research through both an intramural program based at the National Institutes of Health (NIH) Clinical Center and through a broad range of support for external trials conducted by VRC collaborators and partners.​

Translational Research Program

The Translational Research Program (TRP) serves three major functions at the VRC: 1) provides centralized support and service for all in vivo research conducted at the VRC, 2) conducts collaborative research and animal model development, and 3) operates a fully accredited lab animal facility.

Vaccine Immunology Program

The goal of the Vaccine Immunology Program (VIP) is to facilitate the coordinated development and deployment of state-of-the-art technologies and analyses, which can be utilized effectively for vaccine discovery, early development and testing of clinical products.

Vaccine Production Program

The goal of the Vaccine Production Program Laboratory (VPPL) is to efficiently translate candidate research vaccines into materials for proof-of-concept clinical trials and to enable advanced development and licensure by partners.


Content last reviewed on